Wanming Hu Selected Research

Wanming Hu Research Topics

Disease

14	Neoplasms (Cancer) 01/2024 - 10/2013
11	Glioma (Gliomas) 05/2024 - 01/2015
4	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2024
1	Infections 12/2023
1	Hepatocellular Carcinoma (Hepatoma) 11/2022
1	Sarcoma (Soft Tissue Sarcoma) 05/2022
1	Adenocarcinoma 01/2022
1	Meningioma (Meningiomas) 01/2022
1	Cholangiocarcinoma 01/2022
1	Microsatellite Instability 11/2021
1	Colorectal Neoplasms (Colorectal Cancer) 11/2021
1	Adenocarcinoma of Lung 01/2021
1	Extranodal Extension 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Encephalomyelitis (Myeloencephalitis) 01/2019
1	Demyelinating Diseases (Demyelinating Disease) 01/2019
1	Multiple Sclerosis 01/2019
1	Adenoma (Adenomas) 06/2018
1	Oncogenic osteomalacia 06/2018
1	Stomach Neoplasms (Stomach Cancer) 04/2016
1	Inflammation (Inflammations) 04/2016
1	Carcinoma (Carcinomatosis) 10/2013
1	Carcinogenesis 10/2013

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 06/2018 - 10/2013
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2024 - 01/2021
2	Complement System Proteins (Complement)IBA 01/2023 - 01/2019
2	RNA (Ribonucleic Acid)IBA 05/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	Histones (Histone)IBA 01/2022 - 07/2019
2	Lysine (L-Lysine)FDA Link 01/2022 - 07/2019
2	Chemokine ReceptorsIBA 05/2016 - 04/2016
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2016 - 10/2013
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2024
1	Hematoxylin (Haematoxylon)IBA 05/2024
1	Glycoproteins (Glycoprotein)IBA 01/2024
1	AntigensIBA 01/2024
1	Antiviral Agents (Antivirals)IBA 12/2023
1	Interferon-alpha (Interferon Alfa)IBA 01/2023
1	Temozolomide (Temodar)FDA LinkGeneric 01/2023
1	lorlatinibIBA 01/2023
1	Polytetrafluoroethylene (Teflon)FDA Link 11/2022
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2022
1	CateninsIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	LigandsIBA 01/2022
1	Histone MethyltransferasesIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2021
1	SynaptophysinIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2019
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2019
1	AlbuminsIBA 01/2019
1	alpha-internexinIBA 06/2018
1	68Ga-DOTANOCIBA 06/2018
1	Small Interfering RNA (siRNA)IBA 05/2016
1	ChemokinesIBA 04/2016
1	Fluorouracil (Carac)FDA LinkGeneric 04/2016
1	reparixinIBA 04/2016
1	Indicators and Reagents (Reagents)IBA 07/2015
1	Messenger RNA (mRNA)IBA 07/2015
1	CXC ChemokinesIBA 10/2013

Therapy/Procedure

6	Therapeutics 01/2024 - 01/2021
4	Immunotherapy 01/2022 - 01/2019
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2021
2	Adjuvant Chemotherapy 01/2022 - 01/2022
1	Precision Medicine 04/2024
1	Radiotherapy 01/2023
1	Neoadjuvant Therapy 11/2022
1	Molecular Targeted Therapy 01/2022
1	Ablation Techniques 01/2021